







Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. was founded in 2023, and has been adhering to the developing concept of the parent company, NGP, which has always stood strong in the face of inheriting and popularizing the millennial-long TCM culture with modern techniques. We have served many regions around the world, including traditional Chinese medicine clinics, herbal extract wholesalers, medical institutions, and clinics. "We are committed to empowering global pharmacies through an efficient B2B supply chain to safeguard health."
In the contemporary global health market, the demand for high-efficiency, standardized traditional medicine solutions like Xiao Zhi (Specialized Formulas) has reached unprecedented levels. As modern medicine integrates more holistic approaches, TCM granules have transitioned from niche traditional markets to mainstream clinical environments in Europe, North America, and Southeast Asia. The global pharmaceutical industry is currently witnessing a shift where practitioners demand convenience without compromising the bio-active efficacy of traditional herbs.
Our research indicates that the "Xiao Zhi" methodology—which emphasizes precision in concentration and extraction—is now the gold standard for international herbal procurement. Companies are no longer looking for raw herbs; they are searching for scientific consistency. This is where Sichuan Neo-Green excels, providing standardized TCM granules that offer high bioavailability and clear chemical markers for quality control.
The global herbal extract market is projected to grow significantly, driven by an aging population and a preference for natural therapies. Key procurement trends include:
For global enterprises, the challenge is finding a supplier that bridges the gap between ancient wisdom and 21st-century manufacturing science. NGP addresses this through our "Full Value Chain" approach, ensuring that our partners receive products that are safe, effective, and legally compliant in diverse international jurisdictions.
Xiao Zhi products are no longer confined to traditional pharmacy cabinets. In the US and Europe, we see these granules being utilized in:
Localized application also involves adapting flavors and concentrations to suit the preferences of different demographics. Our R&D team works closely with global distributors to ensure that the Xiao Zhi products we supply are optimized for their specific regional markets.
Founded in 2009, Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (NGP) is a comprehensive TCM enterprise integrating research and development, production and operation, especially in the field of TCM granules, which enjoys a high reputation. As a “National Enterprise Technology Center”, “High-tech Enterprise” and “National Key Leading Enterprise in Agricultural Industrialization”, NGP is not only one of the six pilot manufacturers approved by China for the formulation and production of TCM granules, but also the only TCM granule enterprise in the southwestern region of China.
Our manufacturing facility leverages AI-enhanced automation to monitor temperature, pressure, and extraction timing with surgical precision. This ensures that every granule of Xiao Zhi contains the maximum concentration of active ingredients. By choosing NGP, you are partnering with a factory that values the heritage of the past while investing heavily in the technology of the future.







